Pamela Knickerbocker, DO
Family Medicine · Avon Park, FLNPI 1164561353
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,099 of the $21,187 with a category attached, or 94.9%. Organon accounts for 97.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $12,127 and has fallen 98.5% since, to $187 in 2025. Among family medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $516.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$21K
- Amgen$111
- GSK$95
- Dexcom, Inc.$90
- Merck$54
- Abbott$50
- plus $140 from 5 others
What the payments were for
- Speaking & faculty fees$20,09995%
- Travel & lodging$5363%
- Food & beverage$5523%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 21 | $20,646 |
| Amgen | 5 | $111 |
| GSK | 1 | $95 |
| Dexcom, Inc. | 1 | $90 |
| Merck | 3 | $54 |
| Abbott | 2 | $50 |
| AbbVie | 2 | $48 |
| Exact Sciences | 2 | $32 |
| Novo Nordisk | 2 | $29 |
| AstraZeneca | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$17,788
How this compares
$21,187 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 24 | $472 |
| Atorvastatin Calcium | 56 | $359 |
| Losartan Potassium | 21 | $301 |
| Levothyroxine Sodium | 37 | $277 |
| Amlodipine Besylate | 30 | $191 |
| Famotidine | 17 | $169 |
| Pantoprazole Sodium | 11 | $134 |
| Lisinopril | 28 | $123 |
| Omeprazole | 15 | $106 |
| Metformin Hcl | 18 | $76 |
| Rosuvastatin Calcium | 13 | $58 |
| Hydrochlorothiazide | 13 | $52 |
| Furosemide | 20 | $52 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Avon Park
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.